Unknown

Dataset Information

0

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.


ABSTRACT: The efficacy and safety of telmisartan 80?mg/amlodipine 5?mg plus hydrochlorothiazide 12.5?mg (T80/A5/H12.5) was examined for its ability to treat hypertension in Japanese patients whose hypertension is uncontrolled with telmisartan 80?mg/amlodipine 5?mg (T80/A5). Patients aged ?20 years who had essential hypertension despite taking two or three antihypertensive drugs entered a 6-week run-in period on T80/A5. Patients whose hypertension remained uncontrolled were randomly assigned to either the T80/A5/H12.5 group (n=149) or the T80/A5 group (n=160), once daily for 8 weeks. After 8 weeks, patients in the T80/A5/H12.5 group showed a significantly greater adjusted mean reduction in both seated diastolic blood pressure and seated systolic blood pressure than those in the T80/A5 group. Furthermore, more patients achieved a diastolic/systolic blood pressure of <90/140?mm?Hg in the T80/A5/H12.5 group compared with the T80/A5 group. The most common adverse events were nasopharyngitis, elevated blood uric acid levels and hyperuricemia, and the latter two events were more frequent in the T80/A5/H12.5 group than in the T80/A5 group. Overall, T80/A5/H12.5 administered for 8 weeks significantly reduced systolic and diastolic blood pressure and was well tolerated by patients with hypertension uncontrolled with T80/A5.

SUBMITTER: Higaki J 

PROVIDER: S-EPMC5339800 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.

Higaki Jitsuo J   Komuro Issei I   Shiki Kosuke K   Lee Ganghyuck G   Taniguchi Atsushi A   Ikeda Hiroshi H   Kuroki Daisuke D   Nishimura Seiichiro S   Ogihara Toshio T  

Hypertension research : official journal of the Japanese Society of Hypertension 20161020 3


The efficacy and safety of telmisartan 80 mg/amlodipine 5 mg plus hydrochlorothiazide 12.5 mg (T80/A5/H12.5) was examined for its ability to treat hypertension in Japanese patients whose hypertension is uncontrolled with telmisartan 80 mg/amlodipine 5 mg (T80/A5). Patients aged ⩾20 years who had essential hypertension despite taking two or three antihypertensive drugs entered a 6-week run-in period on T80/A5. Patients whose hypertension remained uncontrolled were randomly assigned to either the  ...[more]

Similar Datasets

| S-EPMC8673089 | biostudies-literature
| S-EPMC4819539 | biostudies-literature
| S-EPMC5222993 | biostudies-literature
| S-EPMC6011241 | biostudies-literature
| S-EPMC5857156 | biostudies-literature
| S-EPMC3930838 | biostudies-literature
| S-EPMC3915530 | biostudies-literature
| S-EPMC8020363 | biostudies-literature
| S-EPMC3219858 | biostudies-literature
| S-EPMC7526577 | biostudies-literature